IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 4916 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE here  
     Search
     Current Issue
     Submit Article 
     My Preferences 
     Dermatology crossword 

 


This article has been cited by
1Long-Term Efficacy of Vismodegib After its Withdrawal and Patientsí Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI)
Alessia Villani,Matteo Megna,Gabriella Fabbrocini,Milena Cappello,Maria Antonietta Luciano,Claudia Costa,Massimiliano Scalvenzi
Dermatology and Therapy.2019;9(4)719
[DOI]
2Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test
Alessia Villani,Gabriella Fabbrocini,Milena Cappello,Claudia Costa,Massimiliano Scalvenzi
Dermatology and Therapy.2019;9(3)505
[DOI]
3Vismodegib
Alessia Villani,Gabriella Fabbrocini,Milena Cappello,Claudia Costa,Massimiliano Scalvenzi
Reactions Weekly.2018;1729(1)265
[DOI]
4Efficacy and safety of vismodegib in patients with basal cell carcinoma: An Italian Center experience
Massimiliano Scalvenzi,Alessia Villani,Claudia Costa,Milena Cappello
Dermatologic Therapy.2019;1729(1)e12971
[DOI]
Online since 15th March '04
Published by Wolters Kluwer - Medknow